dyslipidemia


Also found in: Dictionary, Wikipedia.

dyslipidemia

 [dis-lip″id-e´me-ah]
abnormality in, or abnormal amounts of, lipids and lipoproteins in the blood; see hyperlipidemia and hypolipidemia.

dyslipidemia

/dys·lip·id·e·mia/ (-lip″id-e´me-ah) abnormality in, or abnormal amounts of, lipids and lipoproteins in the blood.

dyslipidemia

(dĭs-lĭp′ĭ-dē′mē-ə)
n.
An abnormal concentration of lipids or lipoproteins in the blood.

dys·lip′i·de′mic (-mĭk) adj.

dyslipidemia

[dislip′id·ē′mē·ə]
Etymology: Gk, dys, difficult + lipid + Gk, haima, blood
abnormality in, or abnormal amounts of, lipids and lipoproteins in the blood. See also hyperlipidemia, hypolipoproteinemia.

dyslipidemia

Metabolic disease Any defect in lipoprotein metabolism–eg ↑ cholesterol, ↑ TGs, combined hyperlipidemia, and ↓ HDL-C; dyslipidemias may be 1º–ie nosologies a sui generis or 2º to other medical conditions–eg, DM or hypothyroidism

dys·lip·i·de·mi·a

(dis-lip'i-dē'mē-ă)
Any biochemical disorder characterized by one or more abnormal levels of blood lipids.
References in periodicals archive ?
In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid trial, published on-line in the New England Journal of Medicine,(1) the group with atherogenic dyslipidemia had 70 percent more cardiovascular events (cardiovascular death, heart attacks and strokes) than patients without.
The primary end points were fragility fractures, incident diabetes, incident dyslipidemia, acute MI, and sudden cardiac death.
For the future, researchers called for more well designed studies with long-term outcome data in order to further define the role for guggul, red yeast rice, policosanol, garlic and flaxseed in the management of dyslipidemia.
Fore Pharma announced the results of its Dyslipidemia patient population study in a new report Global Dyslipidemia Epidemiology and Patient Flow Analysis - 2012'.
GlobalData expects that the dyslipidemia drug market will grow at a CAGR of 9.
And 36% of the type 1 diabetic subjects with dyslipidemia were on medication for it--a rate fourfold greater than in dyslipidemic nondiabetic participants in the Denver-based study, in which Dr.
Fore Pharma's latest report 'Global Dyslipidemia Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Dyslipidemia market.
Abstract # 703-P: Saroglitazar Shows Beneficial Effects on Insulin Sensitivity, Dyslipidemia, and Blood Pressure in Zucker Fatty Rats.
Dyslipidemia had no significant impact on PCAD in the subset that combined white and Asian Indian patients, but dyslipidemia increased the odds of PCAD approximately threefold in the subset of black and Hispanic patients.
What are the key parameters of the dyslipidemia market?
Peggy isn't the only one benefitting from access to dyslipidemia medicines through Medicare Part D.
Of 30,629 white patients, 62% were diagnosed with dyslipidemia, and all of those patients were on statin drugs.